Lionsgate Studios Corp. is a US-listed company in the movies & entertainment industry. Its financial year ends in March.
Loading chart…
Third-party market data · may be delayed
~$10
Forward price-to-earnings vs peers
Base case. Range ~$7.6–$19. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.
No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.
Lionsgate Studios Corp. valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 1600% in the quarter to 2026-06-30, the 2nd beat in the last four quarters.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
Lionsgate Studios Corp. said its Compensation Committee approved an amendment to the employment agreement with Chief Financial Officer James W. Barge. The company stated the term of the agreement was extended to January 31, 2027. The amendment was dated October 29, 2026.
We value Lionsgate Studios Corp. as an operating company, with every model that fits that kind of business. Cost of equity 8.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.87 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. | — | Does not apply: no revenue, margin or share count to start from |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$10 ~$7.6–$19 | Included |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. | — 0 | Does not apply: no positive value |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$10 ~$7.6–$19 | 1 model |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Lionsgate Studios Corp. with Movies & Entertainment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Next results: November 5, 2026, after the close. Analysts expect revenue of $629m and EPS of −$0.02 (range −$0.06 to $0.03) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $0.39 | +532% | $3.4bn | +27% |
| Next | $0.49 | +25% | $3.4bn | +2% |
Next year's EPS estimate has moved +23.8% in 90 days, across 7 analysts.
The consensus EPS forecast for the current fiscal year is +15.1% on 90 days ago. In the last 30 days, 2 analysts raised Lionsgate Studios Corp.'s forecast and 2 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $0.34 | $0.39 |
| 60 days ago | $0.32 | $0.44 |
| 30 days ago | $0.40 | $0.51 |
| 7 days ago | $0.39 | $0.49 |
| Now | $0.39 | $0.49 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$0.00 | $0.06 | +1600.0% |
| Mar 2026 | $0.24 | $0.37 | +56.8% |
| Dec 2025 | $0.02 | $0.01 | −45.9% |
| Sept 2025 | −$0.17 | −$0.20 | −15.0% |
Adjusted EPS as companies report it, against the average analyst estimate.
| Calendar year | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|
| Return | ||||
| LION | +7% | −28% | +20% | +33% |
| Industry peers (median) | +4% | +24% | +5% | +10% |
| S&P 500 | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||
| LION | 100% | 58% | 50% | 55% |
| S&P 500 | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||
| LION | −1% | −51% | −38% | −35% |
| S&P 500 | −10% | −8% | −19% | −9% |
Worst fall since March 1, 2022: 55% from May 8, 2024 to July 7, 2025. Getting back needed a 124% gain, reached on May 1, 2026, 298 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| August 6, 2026 | −0.1% | +0.5% | −9.7% | −13.9% |
| May 21, 2026 | +18.7% | +0.6% | +13.9% | +19.0% |
| February 5, 2026 | +1.8% | +0.6% | −10.2% | +18.2% |
| November 6, 2025 | +1.9% | −1.0% | −1.2% | +9.2% |
| August 7, 2025 | +7.8% | +0.7% | +11.6% | +12.4% |
| May 22, 2025 | −1.9% | −0.6% | +7.4% | −10.5% |
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Studio Business | $2.7B | 100.0% | ▼ 16.9% |
| Motion Picture (part of Studio Business) | $1.6B | 60.8% | ▲ 1.2% |
| Television Production (part of Studio Business) | $1B | 39.2% | ▼ 34.9% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $1.7B | 64.7% | ▼ 1.8% |
| Outside the US | $859M | 32.6% | ▲ 9.0% |
| Canada | $70.1M | 2.7% | ▲ 11.3% |
From Lionsgate Studios Corp.'s 10-K filed May 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Mhr Fund Management LLC | $576M | 37.6M | 14.2% | 0.0% |
| Liberty 77 Capital L.P. | $575M | 37.5M | 14.2% | 0.0% |
| Jericho Capital Asset Management L.P. | $288M | 18.8M | 7.1% | 0.0% |
| Blackrock, Inc. | $252M | 16.4M | 6.2% | ▼ 18.7% |
| FMR LLC | $158M | 10.3M | 3.9% | ▲ 125.7% |
| Vanguard Portfolio Management LLC | $158M | 10.3M | 3.9% | ▼ 3.7% |
| Neuberger Berman Group LLC | $157M | 10.3M | 3.9% | ▲ 9.8% |
| Vanguard Capital Management LLC | $142M | 9.3M | 3.5% | ▼ 8.6% |
| Ameriprise Financial Inc | $134M | 8.8M | 3.3% | ▲ 21.5% |
| Wellington Management Group LLP | $114M | 7.4M | 2.8% | New |
| Geode Capital Management, LLC | $93.2M | 6.1M | 2.3% | ▲ 20.4% |
| Jefferies Financial Group Inc. | $88.9M | 5.8M | 2.2% | 0.0% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Lionsgate Studios Corp.'s complete shareholder register. Values are as reported by the filers .
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 797,526 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Sell | 25,173,882 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 1,916,271 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 11,154,680 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 671,924 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Sell | 499,765 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Sell | 1,469,450 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Sell | 3,701,988 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 11,755,412 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Sell | 11,755,412 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 15,804,919 | — | $0 |
| Rachesky Mark H Md Director | July 8, 2026 | Buy | 499,765 | — | $0 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around November 5, 2026 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
